CBD could lessen lung harm brought about by COVID-19 Kumar Jeetendra | October 19, 2020 One way CBD appears to reduce the”cytokine storm” that damages the lungs and kills many individuals with COVID-19 is by enabling an increase in levels of a natural peptide called apelin, which is proven to reduce inflammation and whose levels are dramatically reduced in the face of this storm. Dental College of Georgia and Medical …
Bioceramic embed can animate skull bone recovery Kumar Jeetendra | October 19, 2020 A bioceramic implant has proved to stimulate regeneration of natural skull bone, so that even large cranial defects can be repaired in a way which hasn’t been possible before. Reconstructing major bone and soft-tissue injuries in the skull after an accident or treatment of a brain tumor, blood clot, or hemorrhage is a difficult challenge. …
Zydus Cadila gets speculative USFDA gesture for generic drug Kumar Jeetendra | October 19, 2020 New Delhi, Oct 19 Drug firm Zydus Cadila on Monday said it has received tentative approval from the US health regulator to advertise Tofacitinib extended-release pills, used to treat ulcerative colitis, in the American market. The company has received tentative approval from the US Food and Drug Administration (USFDA) for the item which is the …
Glenmark Pharma gets USFDA gesture for generic drug Kumar Jeetendra | October 19, 2020 New Delhi, Oct 19 (PTI) Glenmark Pharmaceuticals on Monday said it has received approval by the US health regulator to market Sirolimus pills, an immunosuppressant, in the American market. The company”s US-based subsidiary has received final approval from the US Food and Drug Administration (USFDA) for the item which is a generic version of PF …
Cipla launches Nintib to treat Idiopathic Pulmonary Fibrosis Kumar Jeetendra | October 20, 2020 Mumbai, India; October 20, 2020: Cipla Limited (BSE: 500087; NSE: CIPLA EQ; and hereafter referred to as “Cipla”) today announced that it has launched generic Nintedanib for the treatment of Idiopathic Pulmonary Fibrosis (IPF). Available as 100 mg and 150 mg capsules, it will be marketed under the brand name Nintib. This launch marks yet …
Pfizer, BioNTech start consolidated preliminaries of COVID-19 immunization candidate in Japan Kumar Jeetendra | October 20, 2020 Pfizer Inc and BioNTech SE announced on Tuesday the start in Japan of combined Phase I and Phase II clinical trials of the mRNA vaccine candidate against the coronavirus. Earlier, they had agreed to supply Japan with 120 million doses of their experimental coronavirus vaccine in the first half of 2021. Pfizer, which is developing …
China’s Sinovac is sheltered, says Brazil’s leading research organization Kumar Jeetendra | October 20, 2020 São Paulo’s Butantan Institute, one of Brazil’s leading biomedical research centers, which is carrying out the Stage 3 tests, said the two-dose vaccine, called CoronaVac, was secure in a trial thus far involving 9,000 volunteers. But Butantan manager Dimas Covas said data on how effective the vaccine is will not be published until the trial …
Researchers propose that antimalarial medications could be repurposed to treat COVID-19 Kumar Jeetendra | October 20, 2020 An international group of researchers believe there is enough evidence that anti-malarial drugs could be repurposed to treat COVID-19 and they need to be evaluated for efficacy in clinical trials. The review article, published online in Trends in Parasitology, summarizes the evidence for its antiviral and anti-inflammatory properties of particular anti-malarial drugs which could play …
Innovations In Sample Management at Virtual Biobanking Events Kumar Jeetendra | October 20, 2020 Ziath announce their participation in two key virtual symposia for scientists involved in biobanking – the ISBER Virtual Symposium 2020 and the Europe Biobank Week 2020. Registrants to these 2 important online events will be able to listen and learn about the latest innovative sample management products and application solutions that Ziath can provide – …
BDR Pharma launches generic version of Lenvatinib for cancer patients in India Kumar Jeetendra | October 21, 2020 Mumbai, 21st October 2020: BDR Pharmaceutical today announces the launch of 4mg and 10 mg of Lenvatinib under the brand name BDFOIE for the treatment of differentiated thyroid cancer, advanced liver cancer and advanced kidney cancer. Lenvatinib is priced at INR 1620 (4 mg) and INR 2970 (10 mg) for a pack of 10 capsules. …
BioGX Announces FDA Emergency Use Authorization Submission of Extraction-Free Direct RT-PCR Test for COVID-19 Kumar Jeetendra | October 21, 2020 Birmingham, AL, October 13, 2020 – Life Science Newswire – BioGX, a molecular diagnostics solutions company, announced FDA Emergency Use Authorization (EUA) submission of an extraction-free, direct sample addition RT-PCR test for detection of SARS-CoV-2 viral RNA in patients suspected of COVID-19. The Xfree® COVID-19 Direct RT-PCR test (“Xfree COVID-19”) is a complete test in …
In-line Flow Meters for Pure Water Dispensing Kumar Jeetendra | October 21, 2020 Titan Enterprises have been offering in-line flow meters for dispensing liquids such as pure water for nearly 40 years. Today, this type of flow device can fulfil critical roles in measuring the rate of flow and volume of pure water in areas including laboratory water purification dispensers, semiconductor cleaning processes and in a growing number …
